Literature DB >> 18561120

Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.

A J A Deutsch1, A Aigelsreiter, E Steinbauer, M Frühwirth, H Kerl, C Beham-Schmid, H Schaider, P Neumeister.   

Abstract

Chemokine receptors mediate migration and activation of lymphocytes through binding of their ligands. Recent studies have revealed important contributions of chemokine receptors to the development, progression, and dissemination of haematopoietic neoplasms. Because the chemokine receptor expression profile in extragastric MALT lymphoma is unknown, we performed a comprehensive study on tissue samples of parotid glands, parotid glands affected by Sjögren syndrome, extragastric MALT lymphoma, and extranodal diffuse large B-cell lymphoma (eDLBCL) originating from MALT lymphoma (transformed MALT lymphoma). By investigating the expression of 19 chemokine receptors by real-time PCR using a semi-quantitative approach and of four chemokine receptors (CCR1, CCR5, CXCR6, and XCR1) by immunohistochemistry, we show that the chemokine receptor expression profiles of extragastric MALT lymphomas differ substantially from those of extranodal DBLCL, with lower expression of CCR1, CCR8, and CXCR3, and the absence of expression of CX3CR1 and XCR1 in eDLBCL. Expression of CCR6, CCR7, CXCR3, CXCR4, and CXCR5, responsible for B-cell homing to secondary lymphoid tissue, was detected in both B-cell malignancies. Expression of CCR4 was just detected in trisomy 3-positive MALT lymphoma cases. Comparing gastric with extragastric MALT lymphomas, up-regulation of CXCR1 and CXCR2 accompanied by down-regulation of CCR8 and CX3CR1 and loss of XCR1 expression in extragastric MALT lymphomas appear to be key determinants for the site of origin of MALT lymphomagenesis. Our results support a model of stepwise progression of extragastric MALT lymphoma from a non-neoplastic event to Sjögren syndrome, to MALT lymphoma, and finally to overt eDLBCL, guided by differentially expressed B-cell homeostatic and activation-dependent chemokine receptors and their ligands. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561120     DOI: 10.1002/path.2372

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Authors:  Naghmeh Ahmadian Kia; Ahmad Reza Bahrami; Marzieh Ebrahimi; Maryam M Matin; Zeinab Neshati; Mahmood Rais Almohaddesin; Naser Aghdami; Hamid Reza Bidkhori
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

Review 2.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

3.  Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.

Authors:  Kerstin Wenzl; Sybille Hofer; Katharina Troppan; Markus Lassnig; Elisabeth Steinbauer; Marco Wiltgen; Barbara Zulus; Wilfried Renner; Christine Beham-Schmid; Peter Neumeister; Alexander Deutsch
Journal:  Tumour Biol       Date:  2015-10-31

4.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

5.  Gene selection using iterative feature elimination random forests for survival outcomes.

Authors:  Herbert Pang; Stephen L George; Ken Hui; Tiejun Tong
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2012 Sep-Oct       Impact factor: 3.710

6.  C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.

Authors:  Matthew W Anderson; Shuchun Zhao; Weiyun Z Ai; Robert Tibshirani; Ronald Levy; Izidore S Lossos; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2010-03       Impact factor: 2.493

7.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

8.  Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.

Authors:  Susann Stollberg; Daniel Kämmerer; Elisa Neubauer; Stefan Schulz; Ingrid Simonitsch-Klupp; Barbara Kiesewetter; Markus Raderer; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

9.  CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

Authors:  Bridget Charbonneau; Alice H Wang; Matthew J Maurer; Yan W Asmann; Clive S Zent; Brian K Link; Stephen M Ansell; George J Weiner; Nazan Ozsan; Andrew L Feldman; Thomas E Witzig; Julie M Cunningham; Ahmet Dogan; Thomas M Habermann; Susan L Slager; Anne J Novak; James R Cerhan
Journal:  Cancer Immunol Immunother       Date:  2013-06-28       Impact factor: 6.968

10.  Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma.

Authors:  Daniel P Widney; Dorina Gui; Laura M Popoviciu; Jonathan W Said; Elizabeth C Breen; Xin Huang; Christina M R Kitchen; Juan M Alcantar; Jeffrey B Smith; Roger Detels; Otoniel Martínez-Maza
Journal:  AIDS Res Treat       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.